Quality of life and societal costs in hypertrophic cardiomyopathy: protocol of the AFFECT-HCM study

BACKGROUND: Ever since the first description of hypertrophic cardiomyopathy (HCM), the most common genetic cardiac disease, tremendous progress has been made in the evaluation and management of HCM patients, but little attention has been focused on the impact of HCM on societal costs and quality of...

Descripción completa

Detalles Bibliográficos
Autores principales: Schoonvelde, Stephan A. C., Wiethoff, Isabell, Hiligsmann, Mickaël, Evers, Silvia M. A. A., Michels, Michelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bohn Stafleu van Loghum 2023
Materias:
Original Article – Study Design Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188851/
https://www.ncbi.nlm.nih.gov/pubmed/36645545
http://dx.doi.org/10.1007/s12471-022-01753-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188851/
https://www.ncbi.nlm.nih.gov/pubmed/36645545
http://dx.doi.org/10.1007/s12471-022-01753-0

Ejemplares similares